Treatment of refractory, atypical lower extremity ulcers with tissue-engineered skin (Apligraf) [7]

Archives of Dermatology

Volumn 137, Issue 12, 2001, Pages 1660-1661

  Long, R E ^a   Falabella, A F ^a   Valencia, I ^a   Eaglstein, W H ^a   Kirsner, R S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; DAPSONE; HYDROXYUREA; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SILICONE; STEROID; TACROLIMUS;

ADULT; AGED; BIOMEDICAL ENGINEERING; CLINICAL ARTICLE; EPIDERMOLYSIS BULLOSA; FEMALE; FOOD AND DRUG ADMINISTRATION; GRAFT REJECTION; HUMAN; LEG ULCER; LETTER; MALE; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; SKIN GRAFT; SKIN ULCER; TREATMENT INDICATION; TREATMENT OUTCOME; ULCER HEALING; WOUND DRESSING;

ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COLLAGEN; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; TREATMENT OUTCOME; WOUND HEALING;

EID: 0035661694     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (5)

1. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human equivalent
2. Clinical experience with a human skin equivalent for the treatment of venous leg ulcers: Process and outcomes
3. Which venous leg ulcers will heal with limb compression bandages?
4. Hydroxyurea-induced leg ulcer treated with Apligraf
5. Tissue-engineered skin (Apligraf) in the healing of patients with epidermolysis bullosa